15:55 Dec 20
Valiant Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Valiant Laboratories Ltd.
Industry Pharmaceuticals
15:55 Dec 20
Quality
57/100
High Financial Strength
Valuation
18/100
Expensive Valuation
Technical
38/100
Technically Neutral
Strength
4
Weakness
5
Opportunity
0
Threats
0
505.58
Market Cap (Cr)
-50.60
PE Ratio
2.18
Price to Book Ratio
49.9
RSI
0.17 %
Net Profit Margin
Download Our App On:
